Evaluating an AI-assisted triage workflow for retinal diseases
PLOS Digital Health · 15.09.2026 · 5 (9) · e0001700
DOI: 10.1371/journal.pdig.0001700 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Digital Health, online erschienen am 15.09.2026. Verfasst von Doohyun Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: VUNO Inc., Seoul, Korea. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VUNO Inc., Korea Medical Institute.
Abstract (Originalsprache)
The clinical value of artificial intelligence (AI) in fundus photography depends on workflow efficiency as well as diagnostic performance. We evaluated an AI-assisted negative-screening workflow for diabetic retinopathy (DR), retinal vein occlusion (RVO), and age-related macular degeneration (AMD) using 6,904 color fundus photographs independently graded by three retina specialists. In this workflow, AI-negative images were classified as negative without ophthalmologist review, whereas AI-positive images were referred for human interpretation. For each reader–disease pair, the reference standard was agreement between the other two readers; discordant cases were excluded (DR, 1.2%–2.3%; RVO, 0.3%–0.6%; AMD, 6.1%–11.6%). The workflow reduced direct ophthalmologist review to 7.3%–8.0% of images for DR, 11.7%–11.9% for RVO, and 13.5%–16.8% for AMD. For DR, sensitivity decreased significantly (0.9168 to 0.8838; difference, -0.0330; 95% confidence interval [CI], -0.0495 to -0.0165; p < 0.001), whereas specificity did not change significantly (0.9961 to 0.9983; p = 0.183). For RVO, sensitivity was unchanged (0.9807) and specificity did not change significantly (0.9985 to 0.9988; p = 0.320). For AMD, sensitivity decreased significantly (0.8570 to 0.8445; difference, -0.0124; 95% CI, -0.0215 to -0.0033; p = 0.008), whereas specificity did not change significantly (0.9685 to 0.9843; p = 0.324). In an exploratory image-level analysis for at least one target disease, review decreased to 27.7%–30.1%; sensitivity changed from 0.9122 to 0.9039 (difference, -0.0083; 95% CI, -0.0131 to -0.0035; p < 0.001) and specificity from 0.9659 to 0.9804 ( p = 0.334). AI-assisted negative-screening can reduce ophthalmologist workload across multiple retinal diseases, but with disease-specific safety trade-offs: because AI-negative images are not reviewed, reduced sensitivity for DR and AMD means a small proportion of true-positive cases would go undetected, potentially delaying diagnosis and treatment for sight-threatening disease. These results support disease-specific implementation strategies that balance workload reduction against missed positive cases.
Autor:innen und Institutionen
- VUNO Inc., Seoul, Korea.
- Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea.
- Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, United States of America.
ORCID-Profile: Doohyun Park, Jihyeon Baek, Kunho Bae
Förderung
- VUNO Inc.
- Korea Medical Institute
Zitieren
APA
Park, D., Oh, R., Baek, J., & Bae, K. (2026). Evaluating an AI-assisted triage workflow for retinal diseases. PLOS Digital Health, 5(9), e0001700. https://doi.org/10.1371/journal.pdig.0001700
Vancouver
Park D, Oh R, Baek J, Bae K. Evaluating an AI-assisted triage workflow for retinal diseases. PLOS Digital Health. 2026;5(9):e0001700. doi:10.1371/journal.pdig.0001700
BibTeX
@article{Park2026,
author = {Park, Doohyun and Oh, Richul and Baek, Jihyeon and Bae, Kunho},
title = {Evaluating an AI-assisted triage workflow for retinal diseases},
journal = {PLOS Digital Health},
year = {2026},
volume = {5},
number = {9},
pages = {e0001700},
doi = {10.1371/journal.pdig.0001700}
}
EUVIMED